Nanostructured Phthalocyanine Assemblies With Efficient Synergistic Effect Of Type I Photoreaction And Photothermal Action To Overcome Tumor Hypoxia In Photodynamic Therapy

Yuan-Yuan Zhao,Ling Zhang,Zixuan Chen,Bi-Yuan Zheng,Meirong Ke,Xingshu Li,Jian-Dong Huang
DOI: https://doi.org/10.1021/jacs.1c07479
IF: 15
2021-01-01
Journal of the American Chemical Society
Abstract:Most photodynamic therapy (PDT) paradigms work through the highly O-2-dependent type II photoreaction to generate singlet oxygen (O-1(2)). The hypoxic microenvironment of solid tumors severely hampers therapeutic outcomes. Here, we present a novel design that could transfer the photo-physical and photo-chemical properties of traditional phthalocyanine-based photo-sensitizers from type II photoreaction to efficient type I photoreaction and vibrational relaxation-induced photothermal conversion. These features enable the obtained nanostructured phthalocyanine assemblies (e.g., NanoPcAF) to display excellent phototherapies under both normoxic and hypoxic conditions. Moreover, NanoPcAF has a high level of accumulation in tumor tissues after intravenous injection, and 94% of tumor growth is inhibited in a preclinical model at a NanoPcAF dose of 0.8 nmol g(-1) and light dose of 300 J cm(-2).
What problem does this paper attempt to address?